Metabolic impact of pheochromocytoma/paraganglioma: targeted metabolomics in patients before and after tumor removal
Zoran Erlic(University of Zurich), Matthias Kroiß, Martin Faßnacht(University of Würzburg), Martín Reincke(LMU Klinikum), Cornelia Prehn, Graeme Eisenhofer(University Hospital Carl Gustav Carus), Andrzej Januszewicz(Hypertension Institute), Max Kurlbaum, Henri Timmers(Radboud University Nijmegen), Dirk Weismann(Universitäts-Kinderklinik Würzburg), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Jerzy Adamski(National University of Singapore), Aleksander Prejbisz(Institute of Cardiology), Svenja Nölting(University of Zurich), Timo Deutschbein(Klinikum Oldenburg), Susan Richter(University of Auckland), Felix Beuschlein(University of Zurich)
Cited by 27
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2018|927
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791